Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q2 2018 Earnings

14AugExpected
Q3 2017
Q4 2017
Q1 2018
Q2 2018
-41.4
-27.33
-13.26
0.81

Details

Expected EPS
N/A
Actual EPS
0.81
Surprise EPS
0.81
Surprise Percent
+∞%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of 0.81 per share for Q2 2018.

0 Comments

Share your thoughts